At almost every turn, a growing and increasingly belligerent government bureaucracy backed by Corporate taskmasters attempts to thwart our efforts by terrorizing small farmers whose only “crime” is the simple production of nutrient rich foods for their communities or putting on trial alternative cancer doctors actually curing patients without resorting to the life altering and physically agonizing cut, poison, burn approach of chemotherapy and radiation.
Even parents are now targets as those that seek to avoid the horrors of conventional chemotherapy for their ailing children find that they are forced into this outdated and barbaric medical paradigm by government authorities and refused “permission” to seek alternative treatments.
While the odds against us sometimes appear hopeless as we struggle to secure our health and wellness choices, now at least is a time to celebrate.
In recent days, Dr. Stanislaw Burzynski’s four year battle with the Texas Medical Board finally ended with outright dismissal of the case!
For those of you not familiar with the saga of Dr. Stan Burzynski, who was the subject of the 2010 Award Winning Documentary Cancer is Serious Business, here it is in a nutshell;
- For over 10 years, Dr. Burzynski MD has successfully treated terminal cancer patients with the multi-agent gene targeted therapy he discovered in the 1970’s called Antineoplastons.
- Antineoplastons completed Phase II of the required FDA-supervised clinical trials in 2009. Further, the FDA has given permission to begin the final phase of testing which involves randomized controlled clinical trials.
- This highly successful alternative treatment devised by Dr. Burzynski involves designing a personalized cancer treatment for each and every terminal cancer patient under his care based on that patient’s individual and unique genetic markers.
- The individualized treatments include off label use of already existing, FDA approved medications with no surgery, no chemotherapy and no radiation required.
Why has Dr. Burzynski been so relentlessly persecuted first by the United States Government and then the Texas Medical Board for so many years?
Follow the money my friends!
The multi-agent gene targeted therapy called Antineoplastons is a nothing short of a huge medical breakthrough that promises to completely shatter the cut, poison, burn Standard Of Care – surgery, chemotherapy and radiation treatment. When clinical trials are completed and Antineoplastons approved, it will be the first time in history that a single individual and not a pharmaceutical company holds the exclusive patent to manufacture and distribute these gene targeted medicines on the open market.
In essence then, Dr. Burzynski’s work represents a two-fold threat to Big Pharma:
- The thankful demise of cut, poison, burn and the huge, monopolistic profits behind chemotherapy and radiation treatment for cancer.
- The rise of gene targeted cancer treatment with no pharmaceutical industry player profiting from these medicines.
That’s right – Big Pharma completely left out in the cold with regard to the sale and distribution of these new, ground breaking cancer medicines!
Parents have particular reason to rejoice that the case against Dr. Burzynski has been dismissed. One form of childhood cancer – diffuse, intrinsic, childhood brainstem glioma for which conventional medicine has no cure has been cured by Antineoplastons (with dozens of others). [ANP – PubMed 2003] [ANP – PubMed 2006] [ANP – Cancer Therapy 2007] [Rad & other – PubMed 2008] [Chemo/Rad – PubMed 2005]
Congratulations Dr. Burzynski on this huge win against the foes that are attempting to silence you and stop your amazing work. The road ahead is still long until treatment with Antineoplastons is widely available to all Americans, but this recent victory brings a big one home for the little guy!
Sarah, The Healthy Home Economist
Sarah Pope has been a Health and Nutrition Educator since 2002. Her work is dedicated to helping families effectively incorporate the principles of ancestral diets within the modern household. She is a sought after lecturer around the world for conferences, summits, and podcasts.
Her work has been covered by major media including USA Today, ABC, NBC, and many others.